Literature DB >> 14870754

Malignant hyperthermia genetic testing in North America Working Group Meeting. Bethesda, Maryland. September 4-5, 2002.

Yoshitatsu Sei1, Nyamkhishig Sambuughin, Sheila Muldoon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14870754     DOI： 10.1097/00000542-200402000-00058

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  3 in total

1.  Malignant hyperthermia susceptibility diagnosed with a family-specific ryanodine receptor gene type 1 mutation.

Authors:  Takahiro Tanabe; Makoto Fukusaki; Yoshiaki Terao; Kazunori Yamashita; Koji Sumikawa; Keiko Mukaida; Carlos A Ibarra; Ichizo Nishino
Journal:  J Anesth       Date:  2008-02-27       Impact factor: 2.078

2.  Using exome data to identify malignant hyperthermia susceptibility mutations.

Authors:  Stephen G Gonsalves; David Ng; Jennifer J Johnston; Jamie K Teer; Peter D Stenson; David N Cooper; James C Mullikin; Leslie G Biesecker
Journal:  Anesthesiology       Date:  2013-11       Impact factor: 7.892

3.  A double mutation of the ryanodine receptor type 1 gene in a malignant hyperthermia family with multiminicore myopathy.

Authors:  Seul-Ki Jeong; Dong-Chan Kim; Yong-Gon Cho; Il-Nam Sunwoo; Dal-Sik Kim
Journal:  J Clin Neurol       Date:  2008-09-30       Impact factor: 3.077
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.